Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, Jeffrey S. Wasser et al.|The Lancet|2008Cited by 862
Factor VIII replacement is still the standard of care in haemophilia A.Louis M. Aledort, Michael D. Tarantino, Pier Mannuccio Mannucci et al.|PubMed|2019Cited by 101
Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)Terry Gernsheimer, Janet L. Nichol, James N. George et al.|Journal of Thrombosis and Haemostasis|2010Cited by 100
New directions to develop therapies for people with hemophiliaPooja Gogia, Louis M. Aledort, Michael D. Tarantino et al.|Expert Review of Hematology|2023Cited by 23
Safety of anti‐D during pregnancyCaroline Cromwell, Louis M. Aledort, Michael D. Tarantino|American Journal of Hematology|2009Cited by 5